HC Deb 24 July 2002 vol 389 c1431W
Mr. Gordon Prentice

To ask the Secretary of State for Health if he has taken a decision on referring cannabis to NICE for assessment once the clinical trials are completed; and if he will make a statement. [69790]

Mr. Lammy

We referred the use of cannabis derivatives for treatment of the symptoms of multiple sclerosis to the National Institute for Clinical Excellence on 20 May 2002. The precise timetabling of the appraisal is a matter for the Institute.